Literature DB >> 2661843

Hypertonic saline fluid therapy following surgery: a prospective study.

J S Cross1, D P Gruber, K W Burchard, A K Singh, J M Moran, D S Gann.   

Abstract

Successful resuscitation of the injured may be achieved more rapidly and with less fluid using hypertonic crystalloid solutions than with isotonic solutions. This randomized, double-blind study compared 0.9% normal saline (NS) to 1.8% hypertonic saline (HS) in 20 postoperative coronary artery bypass patients suffering uniform injury. Study solutions were administered to maintain physiologic endpoints: heart rate, blood pressure, and pulmonary capillary wedge pressure. The groups were similar with respect to age, body surface area, operative procedure, intraoperative fluid status, and intraoperative and postoperative red cell transfusion requirements. HS patients required 30% less fluid than NS patients and were in negative fluid balance during the study (-1,715 +/- 732 ml/24 hr, HS, vs. +266 +/- 825 ml/24 hr, NS; p less than 0.01). In contrast, NS patients were in positive fluid balance after 8 hours. Moreover, HS patients experienced less chest tube drainage than NS patients (981 +/- 88 ml, HS, vs. 1,700 +/- 285 ml, NS; p less than 0.01). Systemic and pulmonary hemodynamic measurements, oxygen delivery, oxygen consumption, and shunt fraction did not differ between the two groups. Serum sodium and osmolality increased in the HS group and peaked at 12 hours (145.4 +/- 1.4 mEq/L and 308.7 +/- 2.0 mOsm/kg, respectively) and correlated with the volume of HS infused (correlation coefficient = 0.81). No deaths occurred and no complication was attributed the hypertonicity of the solution. We conclude that 1.8% hypertonic saline is a safe alternative to isotonic crystalloid therapy in the fluid management of postoperative patients. Decreased third-space losses may occur with HS as suggested by the lower thoracic losses in the HS group; 1.8% NaCl may be the preferred solution in situations where excess free water administration is not desired, and where interstitial edema is detrimental to function and/or survival.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2661843     DOI: 10.1097/00005373-198906000-00020

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  9 in total

1.  Considerations in the surgical treatment of congenital heart disease in children of Jehovah's Witnesses.

Authors:  D A Cooley; C M Burnett
Journal:  Tex Heart Inst J       Date:  1992

Review 2.  Crystalloid fluid choice in the critically ill : Current knowledge and critical appraisal.

Authors:  Carmen A Pfortmueller; Barbara Kabon; Joerg C Schefold; Edith Fleischmann
Journal:  Wien Klin Wochenschr       Date:  2018-03-02       Impact factor: 1.704

3.  Effects of 7.5% hypertonic saline on fluid balance after radical surgery for gastrointestinal carcinoma.

Authors:  Yong-Sheng Shao; Ying-Tian Zhang; Kai-Qin Peng; Zhuo-Yong Quan
Journal:  World J Gastroenterol       Date:  2005-03-21       Impact factor: 5.742

4.  Small-volume hypertonic saline dextran resuscitation from canine endotoxin shock.

Authors:  J W Horton; P B Walker
Journal:  Ann Surg       Date:  1991-07       Impact factor: 12.969

Review 5.  Salt of the earth or a drop in the ocean? A pathophysiological approach to fluid resuscitation.

Authors:  P Gosling
Journal:  Emerg Med J       Date:  2003-07       Impact factor: 2.740

6.  Half-molar sodium-lactate solution has a beneficial effect in patients after coronary artery bypass grafting.

Authors:  Xavier M Leverve; Cindy Boon; Tarmizi Hakim; Maizul Anwar; Erwin Siregar; Iqbal Mustafa
Journal:  Intensive Care Med       Date:  2008-06-18       Impact factor: 17.440

Review 7.  Hypertonic versus near isotonic crystalloid for fluid resuscitation in critically ill patients.

Authors:  F Bunn; I Roberts; R Tasker; E Akpa
Journal:  Cochrane Database Syst Rev       Date:  2004

8.  Hypertonic saline for fluid resuscitation after cardiac surgery (HERACLES): study protocol for a preliminary randomised controlled clinical trial.

Authors:  Carmen A Pfortmueller; Anna S Messmer; Benjamin Hess; David Reineke; Laura Jakob; Stefanie Wenger; Jan Waskowski; Patrick Zuercher; Frederik Stoehr; Gabor Erdoes; Markus M Luedi; Stephan M Jakob; Lars Englberger; Joerg C Schefold
Journal:  Trials       Date:  2019-06-14       Impact factor: 2.279

Review 9.  Operating room use of hypertonic solutions: a clinical review.

Authors:  Gustavo Azoubel; Bartolomeu Nascimento; Mauricio Ferri; Sandro Rizoli
Journal:  Clinics (Sao Paulo)       Date:  2008-12       Impact factor: 2.365

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.